|
H3F3B expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 8.093600E-01 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
7.677400E-01 |
| Normal-vs-Stage2 |
2.233000E-01 |
| Normal-vs-Stage3 |
7.833800E-01 |
| Normal-vs-Stage4 |
9.279800E-01 |
| Stage1-vs-Stage2 |
9.735700E-02 |
| Stage1-vs-Stage3 |
9.874400E-01 |
| Stage1-vs-Stage4 |
7.167000E-01 |
| Stage2-vs-Stage3 |
2.338000E-01 |
| Stage2-vs-Stage4 |
2.775200E-01 |
| Stage3-vs-Stage4 |
7.063200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
8.846400E-01 |
| Normal-vs-AfricanAmerican |
6.178000E-01 |
| Normal-vs-Asian |
3.873600E-01 |
| Caucasian-vs-AfricanAmerican |
4.434200E-01 |
| Caucasian-vs-Asian |
5.779600E-01 |
| AfricanAmerican-vs-Asian |
6.541000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
7.039200E-01 |
| Normal-vs-Female |
8.685800E-01 |
| Male-vs-Female |
3.212200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
5.792000E-01 |
| Normal-vs-Extreme_Weight |
7.884600E-01 |
| Normal-vs-Obese |
6.777800E-01 |
| Normal-vs-Extreme_Obese |
5.427900E-02 |
| Normal_Weight-vs-Extreme_Weight |
2.790800E-01 |
| Normal_Weight-vs-Obese |
8.355000E-01 |
| Normal_Weight-vs-Extreme_Obese |
1.587760E-01 |
| Extreme_Weight-vs-Obese |
2.809200E-01 |
| Extreme_Weight-vs-Extreme_Obese |
6.097200E-03 |
| Obese-vs-Extreme_Obese |
8.583800E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.136000E-01 |
| Normal-vs-Age(41-60Yrs) |
8.857000E-01 |
| Normal-vs-Age(61-80Yrs) |
4.861000E-01 |
| Normal-vs-Age(81-100Yrs) |
4.245400E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.051200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.703900E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.005800E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.156400E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.116400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.852800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
5.853400E-01 |
| Normal-VS-Type2 PRCC |
5.213500E-02 |
| Normal-VS-KIRP CIMP |
8.099600E-01 |
| Normal-VS-Unclassified PRCC |
5.972800E-01 |
| Type1 PRCC-VS-Type2 PRCC |
8.62830000003534E-07 |
| Type1 PRCC-VS-KIRP CIMP |
9.217600E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
1.086450E-01 |
| Type2 PRCC-VS-KIRP CIMP |
3.134200E-02 |
| Type2 PRCC-VS-Unclassified PRCC |
3.494000E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
3.720800E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.443000E-01 |
| Normal-vs-N1 |
9.257400E-01 |
| Normal-vs-N2 |
1.428790E-01 |
| N0-vs-N1 |
9.556000E-02 |
| N0-vs-N2 |
1.937430E-01 |
| N1-vs-N2 |
2.980200E-01 |
|
|
